1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INCYTE CORP.
Incyte Corp. XNAS: INCY
Await Turnaround
Download real time
70.50 2.95 (4.37%)
31.63% Gain from 52W Low
1.4M
XNAS Volume

XNAS 26 Jun, 2025 12:22 PM (EDT)

Watchlist

Portfolio

Share
CEO Appointment
Incyte rises as it appoints Bill Meury as its CEO, succeeding Herve Hoppenot, effective immediately See details

Incyte Corp. - INCY - stock price prediction, stock price target, analyst ratings from 27 analysts

Incyte Corp. has a share price target of US$ 75, revenue growth forecast of 11.1%, and profit growth estimate of 2711.4% for FY25, based on top 27 analyst calls.

Forecaster Screeners